Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Leukemia, Myeloid, Acute 5Myelodysplastic Syndromes 4Leukemia, Myelomonocytic, Chronic 3Thrombocythemia, Essential 1Recurrence 1Primary Myelofibrosis 1Preleukemia 1Polycythemia Vera 1Neoplasm, Residual 1Myeloproliferative Disorders 1Melanoma 1Leukemia, Myeloid 1Leukemia 1Hematologic Diseases 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Bone Marrow Diseases 1

Interventions

ruxolitinib 16Hydroxyurea 7givinostat hydrochloride 5givinostat 5Phlebotomy 3Aspirin 311-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3bomedemstat 2N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide 2LY2784544 2spartalizumab 1sonidegib 1sabatolimab 1pomalidomide 1pelcitoclax 1peginterferon alfa-2b 1navtemadlin; 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid 1navitoclax 1lestaurtinib 1itacitinib 1imetelstat 1anagrelide 1RG7388 1Pipobroman 1Panobinostat 1ON 01910 1NIS-793 1Lenalidomide 1INCB039110 1Fentanyl 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Polycythemia Vera × sabatolimab × Clear all
NCT04283526 2021-03-04

Study of Select Combinations in Adults With Myelofibrosis

Novartis

Phase 1 Withdrawn
Myeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡